Previous close | 0.0600 |
Open | 0.1000 |
Bid | 0.0000 |
Ask | 0.2200 |
Strike | 85.00 |
Expiry date | 2024-06-21 |
Day's range | 0.0600 - 0.1000 |
Contract range | N/A |
Volume | |
Open interest | 3.25k |
Investors' focus is likely to be on Gilead's (GILD) HIV franchise performance and oncology sales when the company reports first-quarter 2024 results.
Besides Wall Street's top -and-bottom-line estimates for Gilead (GILD), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Gilead Sciences (GILD) closed the most recent trading day at $66.76, moving +0.91% from the previous trading session.